CommercialCoverageMedium impact
Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
Blue Cross & Blue Shield of Mississippi·MS · Gastroenterology, General Surgery·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has updated their policy on transesophageal endoscopic therapies for GERD, classifying all procedures including transoral incisionless fundoplication (EsophyX, MUSE, GERDX), radiofrequency treatments (Stretta procedure), and endoscopic implantation/injection therapies as investigational. This means these procedures are not covered by the plan and claims will be denied.
Action Required
Immediately: Billing team must update system to deny/reject claims for all transesophageal endoscopic GERD therapies including transoral incisionless fundoplication (EsophyX, MUSE, GERDX), Stretta radiofrequency procedures, and endoscopic submucosal implantation/injection procedures for BCBS Mississippi patients. Update encounter forms to alert providers that these procedures are considered investigational and not covered. Claims submitted for these services will be denied.